RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Biocorp Production Stock

Biocorp Production ROA 2024

Biocorp Production ROA

-0.05

Ticker

ALCOR.PA

ISIN

FR0012788065

WKN

A14V4G

In 2024, Biocorp Production's return on assets (ROA) was -0.05, a -287.38% increase from the 0.03 ROA in the previous year.

Biocorp Production Aktienanalyse

What does Biocorp Production do?

Biocorp Production SA is a French company in the medical technology industry that manufactures innovative solutions for drug administration and injections. It was founded in 2004 under the name Biocorp sur mesure by Eric Dessertenne and later transformed into Biocorp Production SA. The business model of Biocorp Production SA is to produce innovative medical devices that can be used in medical applications. The company specializes in the development of smart devices that support injection administration. The devices produced by Biocorp can be operated by medical professionals or by patients themselves. One of the core areas of Biocorp Production SA is the development of smart medical technologies that aid in medication management. One such product is Vyoo, a device that assists patients in injecting medications. It is a digital device that facilitates injection administration and makes dosing safer. In addition to developing smart devices, Biocorp also offers other services, such as in the field of clinical trials for medical applications. The company works closely with pharmaceutical companies to develop medical devices and solutions for drug administration. Another important product is Mallya, an intelligent insulin administration system specifically designed for diabetes patients. It enables automated insulin administration tailored to the patient's needs, thereby improving their quality of life. Furthermore, Biocorp Production SA is also involved in the field of wearable medical technology. One example of a wearable device is Easylog, an electronic device for monitoring medical conditions. This device is particularly useful for patients with chronic diseases such as diabetes or asthma. Over the years, Biocorp Production SA has received numerous awards for its innovative products and services. For example, the company received the Innovation Award at the "Innovation Awards" in Paris in 2017 for the Mallya device. Overall, the company currently employs over 60 employees and has its headquarters in Issoire. It has branches in Germany and the USA. The products of Biocorp Production SA are sold in more than 80 countries worldwide. In summary, Biocorp Production SA is a leading provider of smart medical devices for drug administration and injections. The company strives to develop innovative solutions for the medical industry that are tailored to the needs of patients and medical professionals. With the products of Biocorp Production SA, medication administration becomes safer, easier, and more accurate. Biocorp Production ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Biocorp Production's Return on Assets (ROA)

Biocorp Production's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Biocorp Production's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Biocorp Production's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Biocorp Production’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Biocorp Production stock

What is the Return on Assets (ROA) of Biocorp Production this year?

The Return on Assets (ROA) of Biocorp Production is -0.05 undefined this year.

What was the ROA of Biocorp Production compared to the previous year?

The ROA of Biocorp Production has increased by -287.38% compared to the previous year.

What consequences do high ROA have for investors of Biocorp Production?

A high ROA is advantageous for investors of Biocorp Production, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Biocorp Production?

A low ROA can be unfavorable for investors of Biocorp Production as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Biocorp Production affect the company?

An increase in ROA of Biocorp Production can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Biocorp Production impact the company?

A reduction in the ROA of Biocorp Production can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Biocorp Production?

Some factors that can influence the ROA of Biocorp Production include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Biocorp Production important for investors?

The ROA of Biocorp Production is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Biocorp Production take to improve ROA?

To improve ROA, Biocorp Production can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Biocorp Production pay?

Over the past 12 months, Biocorp Production paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biocorp Production is expected to pay a dividend of 0 EUR.

What is the dividend yield of Biocorp Production?

The current dividend yield of Biocorp Production is .

When does Biocorp Production pay dividends?

Biocorp Production pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biocorp Production?

Biocorp Production paid dividends every year for the past 0 years.

What is the dividend of Biocorp Production?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biocorp Production located?

Biocorp Production is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biocorp Production kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biocorp Production from 9/29/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Biocorp Production pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Biocorp Production in the year 2023?

In the year 2023, Biocorp Production distributed 0 EUR as dividends.

In which currency does Biocorp Production pay out the dividend?

The dividends of Biocorp Production are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biocorp Production

Our stock analysis for Biocorp Production Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biocorp Production Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.